Geneesmiddelafgiftesystemen met gereguleerde afgifte: beïnvloedende factoren

Modified-release drug delivery systems optimize drug therapy by minimizing doses, reducing side effects, and ensuring efficient treatment.

These systems regulate drug release to align with the drug's absorption rate and therapeutic objective.

Drugs having low molecular weights, aqueous solubility above 0.1 mg/mL, and balanced lipophilicity perform best.

Stability is crucial, as drugs unstable in the gastrointestinal tract may require alternative routes like transdermal delivery.

Consistent absorption is vital for effective administration. Oral routes suit stable drugs with doses under 1000 mg, while intramuscular and transdermal routes support extended action or bypass first-pass metabolism.

Pharmacokinetic factors like efficient absorption, an elimination half-life typically between 2 and 4 hours, and consistent metabolism are essential for controlled delivery.

Drugs must also have appropriate pharmacodynamics, including a dose under 1g, a wide therapeutic range, and predictable concentration-response relationships.